Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionOxford Financial Group Ltd
Latest Disclosed Ownership10,168 shares
Latest Disclosed Value $ 373,674
Oxford Financial Group Ltd reports 134.83% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 6, 2026 - Oxford Financial Group Ltd filed a 13F-HR form disclosing ownership of 10,168 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $320,800 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,330 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 134.83% during the quarter. The current value of the position is $364,218 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 10,168 5,838 134.83 374 69.55 0.0201
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 4,330 4,330 220 0.0121
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 0 -3,030 -100.00 0 -100.00
2025-08-14 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 3,030 -620 -16.99 209 -17.39 0.0124
2025-05-15 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 3,650 60 1.67 253 -17.86 0.0178
2025-02-11 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 3,590 -310 -7.95 309 -33.62 0.0200
2024-11-12 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 3,900 -80 -2.01 464 -18.31 0.0294
2024-08-14 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 3,980 910 29.64 568 44.16 0.0375
2024-05-13 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 3,070 -11 -0.36 394 23.90 0.0274
2024-02-14 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 3,081 51 1.68 319 15.64 0.0234
2023-11-13 2023-09-30 13F NOVO-NORDISK A S ADR 670100205 3,030 257 9.27 276 -38.62 0.0238
2023-08-10 2023-06-30 13F NOVO-NORDISK A S ADR 670100205 2,773 2,773 449 0.0427
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.